These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 12207628

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Effects of aging, renal dysfunction, left ventricular systolic impairment, and weight on steady state pharmacokinetics of perhexiline.
    Ling LH, Chik W, Averbuj P, Pati PK, Sverdlov AL, Ngo DT, Morris RG, Sallustio BC, Horowitz JD.
    Ther Drug Monit; 2011 Apr; 33(2):251-6. PubMed ID: 21383654
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Population pharmacokinetics of perhexiline from very sparse, routine monitoring data.
    Hussein R, Charles BG, Morris RG, Rasiah RL.
    Ther Drug Monit; 2001 Dec; 23(6):636-43. PubMed ID: 11802096
    [Abstract] [Full Text] [Related]

  • 10. Absolute oral bioavailability of traxoprodil in cytochrome P450 2D6 extensive and poor metabolisers.
    Taylor TJ, Diringer K, Russell T, Venkatakrishnan K, Wilner K, Crownover PH, Benincosa LJ, Gibbs MA.
    Clin Pharmacokinet; 2006 Dec; 45(10):989-1001. PubMed ID: 16984212
    [Abstract] [Full Text] [Related]

  • 11. Correlation of CYP2D6 genotype with perhexiline phenotypic metabolizer status.
    Barclay ML, Sawyers SM, Begg EJ, Zhang M, Roberts RL, Kennedy MA, Elliott JM.
    Pharmacogenetics; 2003 Oct; 13(10):627-32. PubMed ID: 14515061
    [Abstract] [Full Text] [Related]

  • 12. Assessment of interlaboratory performance in the provision of perhexiline therapeutic drug monitoring services in Australia.
    Sallustio BC, Morris RG.
    Ther Drug Monit; 1999 Aug; 21(4):389-94. PubMed ID: 10442691
    [Abstract] [Full Text] [Related]

  • 13. Can Perhexiline Be Utilized Without Long-Term Toxicity? A Clinical Practice Audit.
    Phuong H, Choi BY, Chong CR, Raman B, Horowitz JD.
    Ther Drug Monit; 2016 Feb; 38(1):73-8. PubMed ID: 26309031
    [Abstract] [Full Text] [Related]

  • 14. Stereoselective handling of perhexiline: implications regarding accumulation within the human myocardium.
    Chong CR, Drury NE, Licari G, Frenneaux MP, Horowitz JD, Pagano D, Sallustio BC.
    Eur J Clin Pharmacol; 2015 Dec; 71(12):1485-91. PubMed ID: 26376650
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Development of Fluorinated Analogues of Perhexiline with Improved Pharmacokinetic Properties and Retained Efficacy.
    Tseng CC, Noordali H, Sani M, Madhani M, Grant DM, Frenneaux MP, Zanda M, Greig IR.
    J Med Chem; 2017 Apr 13; 60(7):2780-2789. PubMed ID: 28277663
    [Abstract] [Full Text] [Related]

  • 17. Validation of a High-Performance Liquid Chromatography-Tandem Mass Spectrometry Method for the Determination of Perhexiline and Cis-Hydroxy-Perhexiline Plasma Concentrations.
    Westley IS, Licari G, Sallustio BC.
    Ther Drug Monit; 2015 Dec 13; 37(6):821-6. PubMed ID: 25774703
    [Abstract] [Full Text] [Related]

  • 18. Perhexiline.
    Ashrafian H, Horowitz JD, Frenneaux MP.
    Cardiovasc Drug Rev; 2007 Dec 13; 25(1):76-97. PubMed ID: 17445089
    [Abstract] [Full Text] [Related]

  • 19. High-performance liquid chromatographic assay of perhexiline maleate in plasma.
    Horowitz JD, Morris PM, Drummer OH, Goble AJ, Louis WJ.
    J Pharm Sci; 1981 Mar 13; 70(3):320-2. PubMed ID: 7264901
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.